|
SALIVARY GLAND RED HERRINGS I - MASSETERIC HYPERTROPHY
Referrals to the Salivary Gland Center (SGC) include a high incidence
of false positives- the red herrings, more about which will be heard
in future issues. In the SGC, the most common entity mistaken for
parotid enlargement is masseter muscle hypertrophy (MH). It is this
muscleÌs proximity to the parotid gland that causes confusion.
The masseter, a thick quadrate masticatory muscle, arises from
the zygomatic arch and inserts into the inferior lateral aspect
and angle area of the mandibular ramus. MH is an asymptomatic persistent
enlargement of one or both masseter muscles resulting from a work
hypertrophy, initiated by clenching, bruxing, or heavy gum chewing.
This occurs primarily in younger patients. In older age groups with
dental deterioration, there is an inability to fully activate the
masseters and any pre-existing MH tends to recede.
Anatomically, most of the masseteric thickness is along the inferior
portion of the mandibular ramus, where the facial contour normally
tapers. With MH, the patientÌs face takes on a characteristic
rectangular configuration (see illustration). Upon activation, the
previously flaccid muscle becomes firm and displays a discrete and
prominent outline. In addition, because of the increased muscle
bulk and tension, bony hyperplasia may be observed radiographically
in the area of the mu scleÌs
insertion. Orally, tooth attrition resulting from bruxing or clenching
may be present.
In contradistinction to MH, parotid swelling tends to accentuate
facial ovality because the major portion of the gland is situated
at a higher facial level adjacent to the ear. The parotid glands
in MH are neither swollen nor tender. The salivary ducts are patent
with a normal flow rate. Non-involvement of the parotids is further
evidenced by normal sialochemical and sialographic findings.
Other than increased masseter muscle fibre length and diameter,
histology reveals no abnormalities. Therefore, therapy is conservative
and involves reassurance, muscle relaxants, psychiatric care, and
dental bite plate construction. Surgery to reduce muscle mass is
only indicated if cosmetic concerns become paramount. Botulinum
toxin therapy has been suggested. It blocks neuromuscular conduction
and leads to muscle atrophy.
The Salivary Gland Center (SGC) was developed because a void existed
in the diagnostic and comprehensive care of patients with salivary
gland problems and/or secretory dysfunction. Since the diversity
of these salivary conditions presents challenges to the clinician,
the SGC is available for referrals.
Louis Mandel, DDS
Director, Salivary Gland Center
(212) 305-9982
|